Multiple Assemblies exist for SMTL entry 1piv
BINDING OF THE ANTIVIRAL DRUG WIN51711 TO THE SABIN STRAIN OF TYPE 3 POLIOVIRUS: STRUCTURAL COMPARISON WITH DRUG BINDING IN RHINOVIRUS 14; X-RAY DIFFRACTION 2.90 Å

SMTL ID
1piv.1
Ligands
POLIOVIRUS TYPE 3 (SUBUNIT VP1); 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE; MYRISTIC ACID
Polypeptides
POLIOVIRUS TYPE 3 (SUBUNIT VP1); POLIOVIRUS TYPE 3 (SUBUNIT VP2); POLIOVIRUS TYPE 3 (SUBUNIT VP3); POLIOVIRUS TYPE 3 (SUBUNIT VP4)
Oligo-state
hetero-1-1-1-1-mer
SMTL ID
1piv.2
Ligands
POLIOVIRUS TYPE 3 (SUBUNIT VP1); 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE; MYRISTIC ACID
Polypeptides
POLIOVIRUS TYPE 3 (SUBUNIT VP1); POLIOVIRUS TYPE 3 (SUBUNIT VP2); POLIOVIRUS TYPE 3 (SUBUNIT VP3); POLIOVIRUS TYPE 3 (SUBUNIT VP4)
Oligo-state
hetero-5-5-5-5-mer
SMTL ID
1piv.3
Ligands
POLIOVIRUS TYPE 3 (SUBUNIT VP1); 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE; MYRISTIC ACID
Polypeptides
POLIOVIRUS TYPE 3 (SUBUNIT VP1); POLIOVIRUS TYPE 3 (SUBUNIT VP2); POLIOVIRUS TYPE 3 (SUBUNIT VP3); POLIOVIRUS TYPE 3 (SUBUNIT VP4)
Oligo-state
hetero-6-6-6-6-mer
SMTL ID
1piv.4
Ligands
POLIOVIRUS TYPE 3 (SUBUNIT VP1); 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE; MYRISTIC ACID
Polypeptides
POLIOVIRUS TYPE 3 (SUBUNIT VP1); POLIOVIRUS TYPE 3 (SUBUNIT VP2); POLIOVIRUS TYPE 3 (SUBUNIT VP3); POLIOVIRUS TYPE 3 (SUBUNIT VP4)
Oligo-state
hetero-1-1-1-1-mer
SMTL ID
1piv.5
Ligands
POLIOVIRUS TYPE 3 (SUBUNIT VP1); 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE; MYRISTIC ACID
Polypeptides
POLIOVIRUS TYPE 3 (SUBUNIT VP1); POLIOVIRUS TYPE 3 (SUBUNIT VP2); POLIOVIRUS TYPE 3 (SUBUNIT VP3); POLIOVIRUS TYPE 3 (SUBUNIT VP4)
Oligo-state
hetero-15-15-15-15-mer